Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan MHLW Quadruples Intractable Disease Budget, Adds Seven New Diseases

This article was originally published in PharmAsia News

Executive Summary

TOKYO - At a Feb. 10 meeting of its expert panel on orphan diseases held for the first time in more than six years, Japan's Ministry of Health, Labor and Welfare disclosed that it is planning to quadruple national budget outlays to ¥10 billion ($110 million) for the state's intractable disease research budget in fiscal 2009 and will designate seven new diseases qualifying for the project
Advertisement

Related Content

Japan’s MHLW to Add Seven Disorders to Federally Funded Intractable Diseases List
Japan’s MHLW to Add Seven Disorders to Federally Funded Intractable Diseases List
Advertisement
UsernamePublicRestriction

Register

SC070794

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel